MONTE ROSA THERAPEUTICS INC's ticker is GLUE and the CUSIP is 61225M102. A total of 49 filers reported holding MONTE ROSA THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $36,846,107 | -30.1% | 7,692,298 | 0.0% | 2.85% | -29.2% |
| Q2 2023 | $52,692,241 | -12.1% | 7,692,298 | 0.0% | 4.02% | -2.9% |
| Q1 2023 | $59,923,001 | +2.4% | 7,692,298 | 0.0% | 4.14% | +25.9% |
| Q4 2022 | $58,538,388 | -7.0% | 7,692,298 | -0.1% | 3.29% | +4.7% |
| Q3 2022 | $62,935,000 | -15.5% | 7,703,205 | 0.0% | 3.14% | -17.9% |
| Q2 2022 | $74,490,000 | -31.0% | 7,703,205 | 0.0% | 3.83% | +22.6% |
| Q1 2022 | $107,999,000 | -31.3% | 7,703,205 | 0.0% | 3.12% | -1.9% |
| Q4 2021 | $157,299,000 | -8.3% | 7,703,205 | 0.0% | 3.18% | +55.9% |
| Q3 2021 | $171,627,000 | -1.9% | 7,703,205 | 0.0% | 2.04% | -10.5% |
| Q2 2021 | $174,863,000 | – | 7,703,205 | – | 2.28% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 1,472,331 | $11,204,439 | 7.40% |
| NEA Management Company, LLC | 7,692,298 | $58,538,388 | 3.29% |
| Cormorant Asset Management, LP | 2,893,717 | $22,021 | 1.47% |
| Alphabet Inc. | 1,464,015 | $11,141,154 | 0.65% |
| Avoro Capital Advisors LLC | 4,325,000 | $32,913,250 | 0.49% |
| Casdin Capital, LLC | 510,882 | $3,887,812 | 0.30% |
| RTW INVESTMENTS, LP | 1,214,572 | $9,242,893 | 0.19% |
| Virtus Investment Advisers, Inc. | 12,638 | $96,175 | 0.06% |
| Woodline Partners LP | 511,351 | $3,891,381 | 0.05% |
| CORNERCAP INVESTMENT COUNSEL INC | 28,192 | $214,541 | 0.04% |